FDA 483 OBSERVATION · #267 OF 1,945 MOST-CITED

Calibration - at intervals, written program, remedial action

FDA cited this observation 112 times across 107 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs112
BY FISCAL YEAR
FY20266
FY20256
FY20246
FY202310
FY20225
FY20214
FY20203
FY201910
FY201817
FY201723
FY201622

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 4.2× the rate of the average FDA-cited firm (32.7% vs 7.8%), across 107 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

The calibration of apparatus and recording devices is not done at suitable intervals in accordance with an established written program.

ACTA Laboratories, Inc. · Foothill Ranch, California · Drugs · 2026-09-04

The calibration of instruments is not done at suitable intervals in accordance with an established written program.

Choksi Laboratories Limited · Indore · Drugs · 2026-08-20

The calibration of instruments is not done at suitable intervals in accordance with an established written program.

Samson Pharmaceuticals, Inc · Commerce, California · Drugs · 2026-04-29

The calibration of instruments and recording devices is not done at suitable intervals in accordance with an established written program.

Iso-Tex Diagnostics, Inc. · Alvin, Texas · Drugs · 2026-02-03

The calibration of instruments, apparatus, gauges and recording devices is not done at suitable intervals in accordance with an established written program.

Hill Dermaceuticals, Inc. · Sanford, Florida · Drugs · 2025-10-14

The calibration of instruments is not done at suitable intervals.

Precare Corp · Hauppauge, New York · Drugs · 2025-10-09

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →